Kevin C. Eggan, PhD

2004- Stem Cell and Regenerative Biology Harvard University, Cambridge, MA, United States 
Stem Cell, Neurodegenerative diseases
"Kevin Eggan"
Mean distance: 15.38 (cluster 32)


Sign in to add mentor
Rudolf Jaenisch grad student 1998-2002 MIT
Douglas A. Melton research scientist 2003-2004 Harvard


Sign in to add trainee
Jennifer Ann Erwin research assistant MIT
Kyle Loh research assistant 2008-2009 Harvard
Menglu Qian grad student 2014- Harvard
Jin Hao grad student 2017- Harvard
Gabriella L. Boulting grad student 2011 Harvard
Shila Mekhoubad grad student 2011 Harvard
Inna Tabansky grad student 2011 Harvard
Julia E. Chung grad student 2013 Harvard
Jackson L. Sandoe grad student 2014 Harvard
Feng Tian grad student 2012-2017
Jin Hao grad student 2017-2022 Harvard
Dieter Egli post-doc Harvard (FlyTree)
Kanchana K. Gamage post-doc 2017- Harvard
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Schwartz JC, Podell ER, Han SS, et al. (2014) FUS is sequestered in nuclear aggregates in ALS patient fibroblasts. Molecular Biology of the Cell. 25: 2571-8
Alami NH, Smith RB, Carrasco MA, et al. (2014) Axonal transport of TDP-43 mRNA granules is impaired by ALS-causing mutations. Neuron. 81: 536-43
Hanada T, Weitzer S, Mair B, et al. (2013) CLP1 links tRNA metabolism to progressive motor-neuron loss. Nature. 495: 474-80
Boulting GL, Eggan KC. (2013) Patient-Specific Pluripotent Stem Cells Genomic and Personalized Medicine. 1: 381-390
Williams LA, Davis-Dusenbery BN, Eggan KC. (2012) SnapShot: directed differentiation of pluripotent stem cells. Cell. 149: 1174-1174.e1
Di Giorgio FP, Boulting GL, Bobrowicz S, et al. (2008) Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation. Cell Stem Cell. 3: 637-48
See more...